A New Approach to Managing Heart Rhythm Issues
Recent clinical data indicates that a structured exercise program significantly reduces the burden of atrial fibrillation in patients. Findings presented at the 2026 ESC Congress highlight that combining initial professional supervision with later home-based activity leads to better outcomes than standard care. Atrial fibrillation, a common condition where the heart beats irregularly, has become a major public health concern as its prevalence continues to rise globally.
While medical guidelines have long suggested lifestyle modifications, many eligible patients remain outside of supervised programs. Doctors currently refer only about 10% of those who qualify for exercise-based rehabilitation. This study aims to fill that gap by testing whether a specific, one-year intervention can lower the time patients spend in an arrhythmic state. The trial, dubbed NEXAF, focused on 295 participants in Norway with a mean age of 64.
Details of the NEXAF Trial Design
The researchers randomized patients to either a standard care group or an exercise intervention group. Those in the exercise group attended eight high-intensity, supervised sessions during the first six weeks. After this period, the program shifted to remote monitoring using smartwatches and mobile applications. Participants in the control group received no structured exercise advice or supervision, relying instead on traditional medical management.
To ensure precision, investigators implanted cardiac monitors in every participant. This hardware allowed the team to track the total time spent in atrial fibrillation with high accuracy throughout the entire year. The primary goal was to compare the percentage of time in AF between the two groups. Quality of life metrics were also assessed using the standard AFEQT questionnaire to see if the physical changes translated to subjective patient wellness.
Impact on Patient Health and Hospitalization
The final results showed a clear benefit for the active group. Patients who underwent the exercise intervention experienced a 45% relative reduction in total AF burden compared to those receiving usual care. Specifically, the intervention group spent 3.9% of their time in AF, while the control group averaged 7.1%. This statistical difference of p=0.016 indicates a meaningful physiological change induced by the regular physical activity.
Secondary findings further underscored the value of this approach. The exercise group showed measurable improvements in cardiorespiratory fitness and lower resting heart rates. Perhaps most importantly for the healthcare system, these patients required fewer hospital visits. The data showed a 37% decrease in total hospitalizations and a 46% reduction in those specifically tied to atrial fibrillation.
Future Implications for Cardiac Care
Although the study found clear physiological gains, it did not observe a statistically significant change in self-reported quality of life scores at the one-year mark. Researchers noted that a 5.6 point improvement in the exercise group compared to 4.4 in the control group did not reach the threshold for clinical significance. This suggests that while heart health metrics improve, patients may not immediately perceive a shift in their daily comfort.
Doctor Bjarne Nes, the principal investigator from the Norwegian University of Science and Technology, stated that the results support a broader rollout of long-term exercise programs in cardiac care. He emphasized that the hybrid model of supervised sessions followed by digital, home-based support is both feasible and resource-efficient for clinics. As cardiac guidelines evolve to include these findings, healthcare providers now have stronger evidence to encourage structured exercise as a primary treatment strategy for atrial fibrillation patients moving forward.